Marwan Fakih/X
Jan 27, 2025, 18:41
Marwan G. Fakih: Phase 1 BOT/BAL with FOLFOX in MSS Metastatic Colorectal Cancer at ASCO GI25
Marwan G. Fakih, Associate Director for Clinical Sciences at City of Hope, posted on X:
“GI/ASCO: We presented our Phase 1 BOT/BAL with FOLFOX in MSS MCRC. 14 patients on the phase 1 study. 10 had prior Ox and 12 had prior chemo, yet ORR was 10/14 patients (majority of the pts had liver mets). The combination was safe with 2 doses of BOT + Q2w FOLFOXBEV/BAT.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 20, 2025, 02:27
Apr 19, 2025, 22:24
Apr 19, 2025, 22:03
Apr 19, 2025, 21:39
Apr 19, 2025, 21:21
Apr 19, 2025, 21:04
Apr 19, 2025, 20:48
Apr 19, 2025, 20:25
Apr 19, 2025, 19:36
Apr 19, 2025, 19:17